NASDAQ: STAA · Industrial Applications and Services · 4 alerts · CIK 718937
Share price
$26.01Close, Nov 16
Market cap
$1.31B
Shares outstanding
50.2MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Ophthalmic GoodsSIC 3851
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Staar Surgical Co filings on SEC EDGAR ↗
STAAR Surgical delivered record nine-month revenue driven by a structural shift from lasers to lenses, though supply constraints in China and temporary margin pressures from ERP implementation impacted the quarter.
STAAR Surgical reported net income of $18.8 million for the first nine months of 2026, a significant recovery from a net loss of $62.1 million in the prior year period. Net sales grew to $270.5 million from $181.6 million year-over-year, driven by improved operating income and reduced restructuring and impairment charges.
STAAR Surgical reported third quarter 2026 net sales of $83.4 million and net income of $5.6 million. The company achieved record year-to-date revenue of $270.5 million and authorized a new $50 million share repurchase program during the period.
STAAR Surgical Company appointed former CEO David Bailey as Chief Commercial Officer, effective September 8, 2026. His compensation package includes an annual base salary of approximately $575,000, a target cash bonus of 60% of base salary, and initial equity grants totaling $2.25 million in value (comprised of an $850,000 sign-on grant and a $1.4 million annual long-term incentive award).